145 filings
Page 4 of 8
8-K
8w7rqgrz
5 May 22
Karuna Therapeutics Reports First Quarter 2022 Financial Results and Provides General Business Update
6:39am
DEFA14A
8kkxp6xfe0gigx82 w7
27 Apr 22
Additional proxy soliciting materials
7:05am
8-K
p3jz56yie7s
24 Feb 22
Other Events
11:55am
S-8
qgdy pwc6r3hk
24 Feb 22
Registration of securities for employees
7:27am
8-K
ex2z cg34
24 Feb 22
Karuna Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides General Business Update
6:43am
8-K
7l0bg xdxl3
22 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
dt431p6enh2suh
9 Nov 21
Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
7:00am
8-K
hkflrwdycsc
4 Nov 21
Karuna Therapeutics Reports Third Quarter 2021 Financial Results and Provides General Business Update
6:38am
8-K
dp2xxrbx4ndsoomm
5 Aug 21
Karuna Therapeutics Reports Second Quarter 2021 Financial Results and Provides General Business Update
6:42am
8-K
ghfobcptz2
23 Jun 21
Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
7:02am
8-K
ce0nyb
22 Jun 21
Submission of Matters to a Vote of Security Holders
12:00am
8-K
tn1bvjw
6 May 21
Karuna Therapeutics Reports First Quarter 2021 Financial Results and Provides General Business Update
6:46am
DEFA14A
rqjjqm pc
27 Apr 21
Additional proxy soliciting materials
7:44am